The present invention relates generally to heterobicyclic containing pharmaceutical agents, and in particular, to heterobicyclic metalloprotease inhibitor compounds. More particularly, the present invention provides a new class of heterobicyclic metalloprotease inhibiting compounds that exhibit an increased potency in relation to currently known metalloprotease inhibitors.
-
Page/Page column 197
(2008/12/05)
Chemical Properties
Storage Temp.:under inert gas (nitrogen or Argon) at 2-8°C